Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a prospective interventional study to assess the effect of sarpogrelate compared with
aspirin in Korean type 2 diabetic patients with atherosclerosis.